Shuren: CDRH Needs More Funding For Active Surveillance, Supply Chain Monitoring

 
• By Elizabeth Orr

In a Tuesday webinar from the Alliance for a Stronger FDA, CDRH head Jeffrey Shuren said that a “politicized and toxic” environment in Washington could limit the agency’s ability to keep up with innovation and responding to new threats.

Jeff Shuren is the Director of the Center for Devices and Radiological Health (CDRH) at the U.S. Food and Drug Administration
Jeff Shuren, seen during a recent Alliance for a Stronger FDA webinar. • Source: Webinar Screengrab

More from Regulation

More from Policy & Regulation